Neural Therapy in Notalgia Paresthetica

Completed

• Conditions: Notalgia Paresthetica

• Registration Number: NCT06508073
• Lead Sponsor: Sisli Hamidiye Etfal Training and Research Hospital

Brief Summary

Patients diagnosed with Notalgia paresthetica and who received neural therapy within the last year were retrospectively screened. In the evaluations before treatment and at the 3rd month after treatment; Numerical rating scale for pain, PainDETECT questionnaire for neuropathic pain, SF-12 for quality of life and 5-D itch scale for itch level were used.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-26
• Status Verified: 2024-07
• Primary Completion: 2024-07-10
• Study Completion: 2024-07-10
• Study First Submitted: 2024-07-12
• Study First Submitted QC: 2024-07-12
• Last Update Submitted: 2024-07-12
• Study First Posted: 2024-07-18
• Last Update Posted: 2024-07-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• the presence of a hyperpigmented skin lesion consistent with NP
• minimum 6 months for duration of disease
• 30-60 aged
• application of neural therapy in a manner appropriate to the diagnosis

Exclusion Criteria

• history of previous surgery or injection in the thoracic region
• presence of another treatment in the same period
• presence of any cardiac or pulmonary disease, malignancy, or advanced psychiatric disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Short Form-12 for Quality of life	12 weeks after treatment	The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.
Numeric Rating Scale for Pain	12 weeks after treatment	A scale between 0 and 10 was used to question the pain level.
PainDETECT Questionnaire for assessing Neuropathic pain	12 weeks after treatment	The questionnaire consists of 9 items and is completed by the patient (no clinical examination is required)\[1\]\[3\]. There are 7 weighted sensory descriptor items (never to very strongly) and 2 items relating to spatial and temporal pain characteristics\[3\]. A total score of 19 or more is indicative of likely neuropathic pain.
5-D Itch Scale	12 weeks after treatment	The 5-D itch scale is a 5-domain disease-specific instrument evaluating the duration, degree (severity), direction (improving, unaltered or worsening), disability (impact on sleep, leisure/social, housework/errands and school/work activities) and distribution (body part affected)

Trial Locations

Locations (1)

University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital; 🇹🇷 Istanbul, Turkey